Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of single-cell spatial biology. The platform features the company's proprietary, multiplexed, single-molecule detection technology, which offers full spatial context at subcellular resolution, all in a workflow that preserves the sample tissue. The platform offers unparalleled sensitivity and specificity that helps scientists detect individual transcripts and rare signals to interpret fundamental biology and rapidly advance the understanding of complex biological questions in critical fields such as oncology, neuroscience, and infectious disease. The technology has been under development since 2016 and is currently available through an oversubscribed early access program.
Company Details
- Employees
- 71
- Founded
- -
- Address
- Alfred-Nobel Straße 10, Gebäude 03,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Bioinformatics, Imaging, Spatial Biology, Genomics, Gene Expression, Transcriptomics, Histology, Pathology, Single Cell, Neuroscience, Infectious Diseases, Oncology, Toxicology, Microscopy, Neuroscience, Agrigenomics, Cell Atlasing, Single-cell.
- HQ
- Monheim am Rhein, Nordrhein-Westfalen
Resolve Biosciences Questions
Resolve Biosciences's website is http://www.resolvebiosciences.com
Resolve Biosciences's LinkedIn profile is https://de.linkedin.com/company/resolve-biosciences
Resolve Biosciences has
71 employees.
View email and phone details for 71
employees at Resolve Biosciences.
Resolve Biosciences's industry is
Biotechnology Research
Resolve Biosciences's top competitors are
Bruker Spatial Biology,
Vizgen,
Spatial Genomics, Inc.,
Standard Biotools,
Alpenglow Biosciences,
Rarecyte, Inc.,
Curio Bioscience,
Nucleai,
Bio-Techne,
Akoya Biosciences, Inc..
Resolve Biosciences's categories are Biotechnology Research
Resolve Biosciences's founding year is 2020
